BACKGROUND AND OBJECTIVES
Antibody testing has a pivotal role in the diagnosis of myasthenia gravis (MG). However, there are limited data on the accuracy of the different methods available for acetylcholine receptor (AChR) and muscle-specific kinase (MuSK) autoantibody (Ab) detection in a real-world setting. Our aim wa...
M. P. Giannoccaro, Lucrezia Serra, A. Grondona et al.· Neurology· 0 citations
Attention to non-seizure outcomes in Developmental and/or Epileptic Encephalopathies (DEs, EEs, DEEs) is growing, and there is increasing interest in understanding key determinants of health-related quality of life (HRQoL) in this population. This study investigates personal and family HRQoL in a real-world pedia...
L. Bergonzini, F. Sperandeo, S. Lelli et al.· Italian Journal of Pediatric...· 0 citations
In this large real-world cohort, early benzodiazepine administration was highly effective for SE management, supporting optimized long-term therapy to reduce SE frequency and severity in DS.
S. Lelli, Federica Ascione, L. Bergonzini et al.· Seizure· 0 citations
Earlier SCB initiation was associated with earlier seizure offset and more favourable developmental outcomes, underscoring the importance of early genetic diagnosis and timely SCB therapy, and the use of SCBs, particularly CBZ and OXC, as first-line therapy in (LOF) KCNQ2-DEE and SeL(F)NE is supported.
C. Millevert, M. Hairabedian, Samuel Dahan et al.· Brain : a journal of neurolo...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
